# Bausch Health Companies Inc. – FDA Inspection, Sep 19, 2019

Source: https://www.keypedia.com/records/fda_inspections/bausch-health-companies-inc/e2abd951-f3e0-411f-b024-d327f2749e14
Source feed: FDA_Inspections

> FDA inspection 1108379 of Bausch Health Companies Inc., September 19, 2019. Classification: No Action Indicated (NAI). 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1108379
- Company Name: Bausch Health Companies Inc.
- Inspection Date: 2019-09-19
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1229765 - 2024-01-19
- FDA Inspection 1190487 - 2022-09-29
- [FDA Inspection 1089615 - 2019-04-26](https://www.keypedia.com/records/fda_inspections/bausch-health-companies-inc/1370a46a-7475-4bc7-aeec-1a1d3c8cf563)
- FDA Inspection 1007199 - 2017-02-17
- [FDA Inspection 914426 - 2015-02-20](https://www.keypedia.com/records/fda_inspections/bausch-health-companies-inc/9fabced7-0287-4c9b-ad69-2c72fef6ff40)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/lauren-n-howard/538f77fe-b977-49c9-a5b3-289cf8a6e886)

Company: https://www.keypedia.com/companies/bausch-health-companies-inc/3ad20d84-706c-4643-9588-53b1986c23f5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c